entertainment -WSS

entertainment

author：fashion 2025-09-07 17:24:27 - browse：2

Scientist walks up a strand of DNA -- First Opinion coverage from STAT — Adobe

Eli Lilly said Tuesday that it will pay $200 million to gene-editing firm Beam Therapeutics for Beam’s stake in Verve Therapeutics, another gene-editing company focused on treatments for heart disease.

The deal, which also includes future milestone payments, is evidence that despite the pressure on biotechnology stocks there is still interest in very early cutting-edge technologies among big pharmaceutical players. It also provides Beam, which announced on Oct. 19 that it would cut 100 jobs, or 20% of its workforce, to save cash, a large infusion of money.

“This is like a true win-win-win deal, which is rare in this business, but it’s really, really exciting to see,” said John Evans, Beam’s CEO, in an interview with STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Vertigo drug brings hope for rare neuron disorder, Niemann

hotspot

WSS

Immune cells and nerve overgrowth may explain recurring UTI pain

Ancient Greek ideas underpin modern concepts of pregnancy

The public health thinking behind the CDC’s new Covid guidance

Medicare drug price negotiation’s day in court

Florida health officials providing scant details on measles cases

Cognito secures funding to test medical device for Alzheimer's

Wikipedia

entertainment

entertainment

What does generative AI mean for health care? We asked experts

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

23andMe had bad news about my health. I wish a person had delivered it

The real point of Kenneth Smith’s execution by nitrogen gas

23andMe had bad news about my health. I wish a person had delivered it

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Tori Bowie and the unacceptable rates of Black maternal death

Microsoft's Peter Lee: Generative AI could help doctors be more human

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Time to name cancers by genetics, not organ of origin, expert says

Wikipedia

Quicker fix for pulse oximeters urged during FDA public meeting

Why Talkspace is targeting Medicare, a tricky market

Woodcock on FDA’s accelerated approval and her next chapter

Vertex non

Some dementia cases could be undiagnosed liver disease

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

leisure time

hotspot

knowledge

hotspot